AskBio Inc clinical trials
Acquired by Bayer, Dec 1, 2020 · source ↗
The registry lists 9 studies whose lead sponsor is AskBio Inc. 3 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 5, 2026.
Before and after it joined Bayer
- First submitted before AskBio Inc became part of Bayer
- 2
- First submitted after AskBio Inc became part of Bayer
- 7
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- AskBio Inc9 studies
Something wrong with this grouping? Tell us on the Bayer page.
Studies
Recruiting first, then most recently updated. Showing 9 of 9. All Bayer studies →
- Open-Label, Multi-Stage Study to Optimize the Intraputaminal Administration of AB-1005 Using a Prescriptive Infusion Algorithm (PIA)Not yet recruitingNCT07215403Phase 2
Sponsor listed in the registry: AskBio Inc · First submitted after AskBio Inc became part of Bayer
- A Study to Evaluate Safety, Tolerability, and Efficacy of AB-1009 Gene Therapy (GAA Gene) in Adult Participants With Late-Onset Pompe Disease (PROGRESS-GT LOPD)RecruitingNCT07282847Phase 1/2
Sponsor listed in the registry: AskBio Inc · First submitted after AskBio Inc became part of Bayer
- AB-1005 Long-Term Follow-up StudyEnrolling by invitationNCT07081841
Sponsor listed in the registry: AskBio Inc · First submitted after AskBio Inc became part of Bayer
- A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD)Active, not recruitingNCT06285643Phase 2
Sponsor listed in the registry: AskBio Inc · First submitted after AskBio Inc became part of Bayer
- A Study to Evaluate the Safety of AB-1003 (Previously LION-101) in Subjects With Genetic Confirmation of LGMD2I/R9 (Part1)Active, not recruitingNCT05230459Phase 1/2
Sponsor listed in the registry: AskBio Inc · First submitted after AskBio Inc became part of Bayer
- AB-1002 in Patients With Class III Heart FailureCompletedNCT04179643Phase 1
Sponsor listed in the registry: AskBio Inc · First submitted before AskBio Inc became part of Bayer
- Pre-Gene Therapy Study in Parkinson's Disease and Multiple System AtrophyCompletedNCT05699460
Sponsor listed in the registry: AskBio Inc · First submitted after AskBio Inc became part of Bayer
- AAV2/8-LSPhGAA (ACTUS-101) in Late-Onset Pompe DiseaseCompletedNCT03533673Phase 1
Sponsor listed in the registry: AskBio Inc · First submitted before AskBio Inc became part of Bayer
- Phosphatase Inhibition by Intracoronary Gene Therapy in Subjects With Non-Ischemic NYHA Class III Heart FailureActive, not recruitingNCT05598333Phase 2
Sponsor listed in the registry: AskBio Inc · First submitted after AskBio Inc became part of Bayer